Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Montana Molecular is a biotechnology company specializing in the development of genetically encoded fluorescent biosensors for live-cell imaging. Their innovative tools enable researchers to monitor real-time cellular signaling dynamics, including second messengers like cAMP, DAG, and calcium, as well as GPCR activity. These sensors are delivered using BacMam technology, making them compatible with a wide range of cell types, including primary cells and neurons. The company's products are widely utilized in high-throughput screening and drug discovery applications within the pharmaceutical industry. By providing high-performance assays, Montana Molecular helps scientists gain deeper insights into complex biological processes and accelerate the development of new therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Montana Molecular.